BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1661979)

  • 1. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
    Gupta CK; Sokhey J; Gupta RK; Singh H
    Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
    Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
    Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
    Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P; Trudel M; Thibodeau L; Lecomte J
    Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybridoma antibodies to poliovirus N and H antigen.
    Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
    Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
    [No Abstract]   [Full Text] [Related]  

  • 8. Production and potential use of monoclonal antibodies against polio viruses.
    Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
    Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of monoclonal antibodies for the intratypic differentiation of strains of poliomyelitis type I virus].
    Lashkevich VA; Mustafina AN; Koroleva GA; Gracheva LA; Grishina KG
    Vopr Virusol; 1987; 32(2):183-8. PubMed ID: 2440185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of hybrid cell lines secreting monoclonal antibodies against poliovirus Type 2.
    Guo R; Tang EH; Jiang YQ; Wen YL; Lu FM; Lin JY
    Chin Med J (Engl); 1983 Sep; 96(9):669-74. PubMed ID: 6317298
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of 25 hybridomas secreting monoclonal antibodies against type 1 polio viruses (Sabin strain) and their application in antigenic analysis].
    Gu FZ; Mu GF; Wang YA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):157-61. PubMed ID: 6098380
    [No Abstract]   [Full Text] [Related]  

  • 13. Sero-conversion after oral polio vaccine.
    Hardas UD; Pathak AA; Jahagirdar VL
    Indian J Pediatr; 1978 Oct; 45(369):310-3. PubMed ID: 220192
    [No Abstract]   [Full Text] [Related]  

  • 14. A human-human hybridoma which produces antibodies to polioviruses.
    Chu CT; Yang SY; Yang CS
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):284-8. PubMed ID: 2561573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
    Gu FZ; Wang SH; Sun YY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Production of monoclonal antibodies against rabies virus].
    Akacem O; Benmansour A; Benhassine M
    Arch Inst Pasteur Alger; 1986; 55():269-74. PubMed ID: 3275401
    [No Abstract]   [Full Text] [Related]  

  • 19. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the virus content in oral trivalent candy poliovaccine using monoclonal antibodies to poliovirus].
    Chen SF; Jiang SD; Guan ZD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):72-3. PubMed ID: 3017590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.